Primary Cutaneous T-Cell/Histiocyte-Rich B-Cell Lymphoma: A Case Report and Literature Review

References

• Ott G. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings. Br J Haematol. 2017;178(6):871–887. doi:10.1111/bjh.14744
   PubMed Web of Science ®Google Scholar
• Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol. 2015;90(5):687–706. doi:10.1590/abd1806-4841.20153638
   PubMed Web of Science ®Google Scholar
• Venizelos ID, Tatsiou ZA, Mandala E. Primary cutaneous T-cell-rich B-cell lymphoma: a case report and literature review. Acta Dermatovenerol Alp Pannonica Adriat. 2008;17(4):177–181.
   PubMedGoogle Scholar
• Arai E, Sakurai M, Nakayama H, Morinaga S, Katayama I. Primary cutaneous T-cell-rich B-cell lymphoma. Br J Dermatol. 1993;129(2):196–200. doi:10.1111/j.1365-2133.1993.tb03529.x
   PubMed Web of Science ®Google Scholar
• Krishnan J, Wallberg K, Frizzera G. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol. 1994;18(5):455–465. doi:10.1097/00000478-199405000-00004
   PubMed Web of Science ®Google Scholar
• Dommann SN, Dommann-Scherrer CC, Zimmerman D, Dours-Zimmermann MT, Hassam S, Burg G. Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. Am J Dermatopathol. 1995;17(6):618–624. doi:10.1097/00000372-199512000-00017
   PubMed Web of Science ®Google Scholar
• Take H, Kubota K, Fukuda T, Shinonome S, Ishikawa O, Shirakura T. An indolent type of Epstein-Barr virus-associated T-cell-rich B-cell lymphoma of the skin: report of a case. Am J Hematol. 1996;52(3):221–223. doi:10.1002/(SICI)1096-8652(199607)52:3<221::AID-AJH16>3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Sander CA, Kaudewitz P, Kutzner H, et al. T-cell-rich B-cell lymphoma presenting in skin. A clinicopathologic analysis of six cases. J Cutan Pathol. 1996;23(2):101–108. doi:10.1111/j.1600-0560.1996.tb01282.x
   PubMed Web of Science ®Google Scholar
• Wollina U. Complete response of a primary cutaneous T-cell-rich B cell lymphoma treated with interferon alpha2a. J Cancer Res Clin Oncol. 1998;124(2):127–129. doi:10.1007/s004320050144
   PubMed Web of Science ®Google Scholar
• Dunphy CH, Nahass GT. Primary cutaneous T-cell-rich B-cell lymphomas with flow cytometric immunophenotypic findings. Report of 3 cases and review of the literature. Arch Pathol Lab Med. 1999;123(12):1236–1240. doi:10.5858/1999-123-1236-PCTCRB
   PubMed Web of Science ®Google Scholar
• Gogstetter D, Brown M, Seab J, Scott G. Angiocentric primary cutaneous T-cell-rich B-cell lymphoma: a case report and review of the literature. J Cutan Pathol. 2000;27(10):516–525. doi:10.1034/j.1600-0560.2000.027010516.x
   PubMed Web of Science ®Google Scholar
• Kamarashev J, Dummer R, Schmidt MH, Kempf W, Kurrer MO, Burg G. Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin’s disease in a patient with Gardner’s syndrome. Dermatology. 2000;201(4):362–365. doi:10.1159/000051557
   PubMed Web of Science ®Google Scholar
• Li S, Griffin CA, Mann RB, Borowitz MJ. Primary cutaneous T-cell-rich B-cell lymphoma: clinically distinct from its nodal counterpart? Mod Pathol. 2001;14(1):10–13. doi:10.1038/modpathol.3880250
   PubMed Web of Science ®Google Scholar
• Watabe H, Kawakami T, Soma Y, Baba T, Mizoguchi M. Primary cutaneous T-cell-rich B-cell lymphoma in a zosteriform distribution associated with Epstein-Barr virus infection. J Dermatol. 2002;29(11):748–753. doi:10.1111/j.1346-8138.2002.tb00215.x
   PubMed Web of Science ®Google Scholar
• Vezzoli P, Fiorani R, Girgenti V, et al. Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature. Dermatology. 2011;222(3):225–230. doi:10.1159/000327376
   PubMed Web of Science ®Google Scholar
• Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol. 1988;12(6):433–443. doi:10.1097/00000478-198806000-00003
   PubMed Web of Science ®Google Scholar
• Wolff DJ, Bagg A, Cooley LD. Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007;9(2):134–143. doi:10.2353/jmoldx.2007.060128
   PubMed Web of Science ®Google Scholar
• Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032. doi:10.1182/blood-2011-01-293050
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar
• Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas [published correction appears in Blood. 2019 Sep 26;134(13):1112]. Blood. 2019;133(16):1703–1714. doi:10.1182/blood-2018-11-881268
   PubMed Web of Science ®Google Scholar
• Grimm KE, O’Malley DP. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. Ann Diagn Pathol. 2019;38:6–10. doi:10.1016/j.anndiagpath.2018.09.014
   PubMed Web of Science ®Google Scholar
• Selva R, Violetti SA, Delfino C, et al. A literature revision in primary cutaneous B-cell lymphoma. Indian J Dermatol. 2017;62(2):146–157. doi:10.4103/ijd.IJD_74_17
   PubMed Web of Science ®Google Scholar
• Ng CS, Chan JK, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol. 1989;20(12):1145–1154. doi:10.1016/s0046-8177(89)80004-8
   PubMed Web of Science ®Google Scholar
• Wang J, Sun NCJ, Chen YY, Weiss LM. T-cell /histiocyte-rich B cell lymphoma displays a heterogeneity similar to diffuse large B cell lymphoma: a clinicopathologic, Immunohistochemical, Molecular study of 30 cases. Appl Immunohistochem Mol Morphol. 2005;13(2):109–115. doi:10.1097/01.pai.0000132199.47017.35
   PubMedGoogle Scholar